cannaponics company logo

Cannaponics Limited

World leading integrated medical cannabis company

A licensed producer of medicinal cannabis including cultivation, manufacturing and research company.

Business Highlights

  • Australia’s first medicinal cannabis tolling service by providing third party tolling services

  • New vertically integrated medicinal cannabis company leveraging renewable energy resources in Australia

  • Focused on manufacturing pharmaceutical grade medicinal products under the European Union Good Manufacturing Practices (*EU GMP) framework

  • Focused on cultivating medicinal cannabis under the World Health Organisation(WHO) quality framework for Good Agricultural and Collection Practices (GACP)

Point of Difference

  • Freehold 165 acres of land in the best climate for cannabis cultivation in WA.
  • World-leading agri-pharma team for cultivation and medicines manufacture.
  • Fully integrated ESG for medicinal cannabis toll production and distribution.
  • b2b focus.
  • 3 Sales Offtake Agreements -at a minimum of $9m of product over 2 years.
  • Innovative Research and Development (R&D) from cultivation to exclusive licences with New Age Nanotech nano-emulsion and GATC DNA testing for personalised medicines.
  • Cutting edge cultivation, value-added extraction and manufacturing equipment.
  • Recipient of $2m of matching Government funding and applying for another $2m in 2023.

Transaction Overview

Number of Shares on Offer 20,000,000
Cost per Share A$0.20
Minimum per Investor A$20,000
Capital Raise Amount A$4,000,000

 

Cannaponics Ltd is aiming to raise A$4M investment capital to help build and operationalize Stage 1 of the new facility. This capital raise is specific to building and operationalizing ‘The Hub’ of the Cannaponics facility. The Hub comprises medicinal cannabis cultivation, post-harvest production, product research and development, industrial scale EU GMP pharmaceutical manufacture, and global wholesale distribution. Q1 2023, The new site is targeted to be built, commissioned and operational. Q2 2023, the first harvest is targeted, and the first products grown on site are aimed to be released for commercial sale.

Business Overview

New vertically integrated medicinal cannabis company leveraging renewable energy resources in Australia. Focused on cultivating medicinal cannabis under the World Health Organisation (WHO) quality framework for Good Agricultural and Collection Practices (GACP). Will be manufacturing pharmaceutical-grade medicinal products under the European Union Good Manufacturing Practices (*EU GMP) framework. Cannaponics is aiming to be Western Australia’s first medicinal cannabis tolling service by providing third party tolling services.

Why Cannaponics?

  • Australian owned and operated
  • Eco-friendly medicinal cannabis
  • Fully licensed Office of Drug Control
  • Industrial scale Agri-Pharma
  • Funded by WA State Gov $2M
  • R&D Tax Rebates & Arena Funding
  • Low cost power medicinal cannabis
  • EU GMP quality standards
  • Industrial scale production
  • Hi-tech drying and extraction
  • Exclusive Licences global partners
  • Growing the Regional WA economy

OVERVIEW

  • Own a freehold 165 acres of land which is the best climate for cannabis cultivation.
  • World leading agri-pharma team for cultivation and medicines manufacture.
  • Fully integrated ESG for medicinal cannabis toll production and distribution.
  • 15 domestic and international distribution channels.
  • Focussed innovative R&D from cultivation to exclusive licences with New Age Nanotech Nano-emulsion and GATC DNA testing for personalised medicines.
  • Pending outcome $5m advanced manufacturing Federal Government Grant.

Cannaponics is near completion of a 3,600sqm Greenhouse (pictured below) and will complete the 2,000sqm EU GM Manufacture facility by Q2 2023, on its 165-acre freehold property in Collie WA, which will produce dried cannabis flower to be further processed into Cannaponics medicinal products. The whole project aims to use 100% renewable resources with Cannaponics subsidiary company CannaEnergy, building a 25,000 sqm solar electrical power hydrogen micro-grid with advanced water harvesting technology.

Business Segments 

Cannaponics
A renewable resource, licensed producer for medicinal cannabis cultivation, manufacturing and research. The facility will be EU GMP compliant on our 165-acre freehold property in Collie, Western Australia.

CannaEnergy
Another subsidiary wholly owned by Cannaponics, CannaEnergy will use 100% renewable resources to power the Cannaponics facility, leveraging advanced technology via a 25,000sqm solar power and hydrogen electrical power micro-grid coupled with water harvesting technology.

 

Australian Owned  and Operated

Eco-Friendly Medical Cannabis

Industrial Scale Agri-Pharma

Exclusive Licences Global Partners

Videos

Announcements

First Mover in Carbon Neutral Economy

Read more

Cannaponics Sign MOU with Avacare Health Australia

Read more

Ewave Signs Licence with Cannaponics

Read more

Team

Rod Zakostelsky

Founder & Managing Director

Jay Stephenson

Director and Company Secretary

Stephen Birkbeck

Chairman

Eric J. Mathur

Chief Scientist

Kenneth Langford

Director of Cultivation

Willie Ooi

Chief Financial Officer

    Thank you for your enquiry.
    We will be in touch as soon as possible.